Salient Surgical Technologies, a privately held medical technology company that develops and markets advanced energy devices for use in surgical procedures, has settled patent infringement lawsuit against Bovie Medical.
Under the terms of the settlement, Bovie will immediately exit the monopolar and bipolar saline-enhanced RF device business (including Bovie’s SEER and BOSS) worldwide, until February 2015.
In addition, Bovie acknowledges the validity and enforceability of Medtronic’s patent – to which Salient has exclusive legal rights – in the US and Europe and in exchange, Medtronic will make a one-time payment to Bovie of $750,000.
Salient president and CEO Joseph Army said they are pleased with the outcome and will continue to defend their intellectual property.